Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation-Reference-Cited by-同舟云学术

Multidrug-resistant tuberculosis patients expressing the HLA-DRB1*04 allele, and after treatment they show a low frequency of HLA-II+ monocytes and a chronic systemic inflammation

Published:2021-04 Issue: Volume:153 Page:104793
ISSN:0882-4010
Container-title:Microbial Pathogenesis
language:en
Short-container-title:Microbial Pathogenesis

Author:

Ocaña-Guzman Ranferi,Tellez-Navarrete Norma A.,Preciado-Garcia Mario,Ponce-Gallegos Marco Antonio^ORCID,Buendia-Roldan Ivette^ORCID,Falfán-Valencia Ramcés,Chavez-Galan Leslie^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology

Reference41 articles.

1. GLOBAL TUBERCULOSIS REPORT 2020,2020

2. TUBERCULOSIS EN LAS AMÉRICAS 2019,2019

3. Multidrug resistant and extensively drug resistant bacteria: a study;Basak;J. Pathog.,2016

4. CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: toward the construction of an optimal anti-tumor vaccine;Accolla;Front. Immunol.,2019

5. Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients;Terán-Escandón;Chest,1999

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Compounds Derived from 5‐Fluoropyridine and Benzo[b]thiophene: Killing Mycobacterium tuberculosis and Reducing its Virulence;Chemistry & Biodiversity;2024-09-13

2. Clinical course of respiratory tuberculosis relapses in the Kazakh population depending on HLA-DRB1 gene alleles;VirusDisease;2024-06

3. Plasma cytokine levels as markers of pathogenesis and treatment response in patients with non-tuberculous mycobacterial pulmonary disease;Brazilian Journal of Medical and Biological Research;2024

4. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial;PLOS ONE;2023-05-17

5. Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management;Frontiers in Cellular and Infection Microbiology;2022-09-23